Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism

Table 2

Homocysteine, hs-CRP, Fibrinogen, and PAI-1 levels in Thyroidism groups.

	SCHypo	CHypo	SCHyper	CHyper	Control
Homocysteine (mmol/L)	12,76±3,11	15,05±9,87	11,93±3,72	10,23±3,13	8,41±3,86
Hs-CRP (mg/L)	5,98±7,84	5,41±3,48^∗	3,80±1,72	3,93±1,91	3,48±0,64
Fibrinogen (mg/dL)	327,56±100,84^∗	283,00±81,16	275,37±68,42	273,56±76,08	271,50±52,47
PAI-1 (ng/mL)	52,21±31,93	42,78±33,65	53,83±37,21	64,19±34,38	54,06±33,78

^∗𝑃<0.05.
PAI-1: plasminogen activator inhibitor-1; SCHypo: subclinical hypothyroidism; CHypo: clinical hypothyroidism; SCHyper: subclinical hyperthyroidism; CHyper: clinical hyperthyroidism.